Λίστα αντικειμένων
Presenter: Evangelia Arampatzi, CRA
Participants: Prof. Spyridonidis, Dr Liga, Dr Tsokanas, Sagiadinou E., Panagi Z.
Today, on 16 March 2022 training about study protocol "AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter, Study to Evaluate Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy" was performed for site initation.
Participants: Prof. Spyridonidis, Dr Liga, Dr Tsokanas, Sagiadinou E., Panagi Z.
Today, on 16 March 2022 training about study protocol "AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter, Study to Evaluate Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy" was performed for site initation.